Marcel v. La. State Dept. of Public Health

492 So. 2d 103
CourtLouisiana Court of Appeal
DecidedJune 24, 1986
DocketCA 85 0497
StatusPublished
Cited by14 cases

This text of 492 So. 2d 103 (Marcel v. La. State Dept. of Public Health) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marcel v. La. State Dept. of Public Health, 492 So. 2d 103 (La. Ct. App. 1986).

Opinion

492 So.2d 103 (1986)

David MARCEL, as Administrator of the Estate of his Minor Child, Dena Marcel
v.
LOUISIANA STATE DEPARTMENT OF PUBLIC HEALTH (DEPARTMENT OF HEALTH & HUMAN RESOURCES), State of Louisiana, Dr. J. Milo Aitkens, XYZ Insurance Company and ABC Insurance Company.

No. CA 85 0497.

Court of Appeal of Louisiana, First Circuit.

June 24, 1986.
Writ Denied October 3, 1986.

*104 Charles Hanemann, Houma, for plaintiff and appellee David Marcel.

Dale P. Martin, Morgan City, for defendants and appellants Dept. of Health & Human Resources and State of La.

Paul D. White Jr., Alexandria, for defendant J. Milo Aitkens, M.D.

Before CARTER, SAVOIE and ALFORD, JJ.

ALFORD, Judge.

Defendants appeal the trial court judgment in favor of plaintiff, David Marcel, awarding him $1,303,936.57, together with legal interest and costs, as administrator of the estate of his minor child, Dena, for damages caused by the defendants' failure to diagnose a genetic disorder known as phenylketonuria (PKU) in Dena as an infant.

Appellants are the Louisiana State Department of Health (now the Department of Health and Human Resources and hereinafter referred to as DHHR) and the State of Louisiana (State).[1]

BACKGROUND

Dena was born on August 18, 1975. Pursuant to DHHR and State requirements, her physician collected a blood sample from Dena on August 27, 1975, and forwarded it to DHHR's diagnostic laboratory to be screened for PKU by a Guthrie test. On September 3, 1975, DHHR reported to Dena's physician that the initial test was positive, with a 12 mg % reading. As prescribed by state regulations and guidelines issued by DHHR, Dena's doctor collected blood for a second Guthrie test for PKU on September 4, 1975, and forwarded it to DHHR. DHHR reported the results of this test as negative on September 9, 1975, and instructed Dena's doctor to perform a ferric chloride urine test. Dena's physician complied, and the results were reported as negative on October 21, 1975. No further action was taken. DHHR failed to followup *105 and request the two additional ferric chloride tests called for by its own requirements and closed its file on Dena without the required report.

Dena's doctor continued to treat her for various ailments through September 29, 1976. After that time, Dena was treated repeatedly for various complaints by several other physicians, none of whom suspected that Dena had PKU. As an infant and toddler, Dena experienced developmental delays in regard to sitting, walking and talking and had recurrent skin problems. In the spring of 1981, Dena's mother noticed that Dena was experiencing staring episodes. On July 1, 1981, Dena was referred to Dr. M. Caroline Duncan, a pediatrician and pediatric neurologist at LSU School of Medicine. After examining Dena, Dr. Duncan mentioned PKU as one of several possibilities and had a screening test run for PKU on blood samples taken from Dena. Test results from this test and subsequent tests showed that Dena had an elevated phenylalanine level. In late July, Dr. Duncan referred Dena to Dr. Emmanuel Shapira, a physician and professor of pediatrics, pathology and biochemistry at Tulane Medical School. After examining Dena on July 23, 1981, Dr. Shapira informed the Marcels that he considered PKU a possibility and suggested that she be admitted to the hospital for definitive testing. He placed Dena on a phenylalanine restricted diet for testing purposes prior to her hospitalization on August 5, 1981. He withheld specific diagnosis until protein loading tests were performed in the hospital, since a high phenylalanine count could indicate conditions other than PKU. On August 8, 1981, Dr. Shapira told Dena's parents for the first time that the test results were indicative of PKU. By letters of August 14 and August 25, 1981, he confirmed the PKU diagnosis.

Because of the PKU, Dena is mentally retarded in the moderate range. More likely than not, her IQ will continue to fall. She attends a special education class, her physical development is impaired and she is subject to seizures which must be controlled by medication. Had Dena's PKU been diagnosed as an infant and had Dena been started on a phenylalanine restricted diet within the first few months of life, she would not have suffered the above described defects.

Plaintiff filed the instant negligence suit on July 29, 1982. Defendants answered, denying any negligence and filed an exception of prescription and/or peremption. The trial court, after hearing the evidence and reviewing the depositions entered into evidence, determined that the plaintiff's cause of action had not prescribed and found defendants negligent for failure "to establish and implement an effective program for identifying PKU," for failure to follow up on positive test, for failure to initiate treatment, for failure to conduct the second Guthrie test properly, and for failure "to adhere even to its own ineffective Guidelines and Procedures." The court held that the defendants' negligence was the direct cause-in-fact of Dena's permanent and irreversible mental retardation with the accompanying physical disorders and awarded plaintiff $1,000,000 in general damages and $303,936.57 for economic loss. We agree and affirm.

PRESCRIPTION

Defendants appeal, alleging the trial court erred in denying their exception of prescription and/or peremption. In support of this allegation, defendants claim that LSA-R.S. 9:5628, which became effective on September 12, 1975, applies to the instant case. The trial court concluded that DHHR and the State are not parties protected by the three-year liberative prescription of LSA-R.S. 9:5628. We agree.

LSA-R.S. 9:5628 provides:

A. No action for damages for injury or death against any physician, chiropractor, dentist, or hospital duly licensed under the laws of this state, whether based upon tort, or breach of contract, or otherwise, arising out of patient care shall be brought unless filed within one year from the date of the alleged act, omission or neglect, or within *106 one year from the date of discovery of the alleged act, omission or neglect; provided, however, that even as to claims filed within one year from the date of such discovery, in all events such claims must be filed at the latest within a period of three years from the date of the alleged act, omission or neglect. (Emphasis ours)

This statute applies only to actions against the entities listed above. It is apparent that the DHHR, its diagnostic laboratory that performed the Guthrie tests on Dena in 1975, and the State are not physicians, chiropractors or dentists. The defendants also do not qualify as a "hospital" for malpractice purposes as defined by LSA-R.S. 40:1299.41.A(4) or LSA-R.S. 40:2102. Defendants' contention that the diagnostic laboratory is a physician's clinic within the meaning of LSA-R.S. 40:1299.41.A(4) is without merit.[2] Thus, by its own terms, LSA-R.S. 9:5628 is inapplicable to the instant case, and any discussion of when the three-year prescriptive period should start to run or of whether or not the statute should be retroactively applied is pretermitted.

The trial court determined that the liberative prescription applicable to the case at bar is the one-year prescriptive period for delictual actions, La.Civ.Code art. 3492 (formerly La.Civ.Code arts. 3536 and 3537), and that prescription had not run. We agree.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Church Mutual Insurance Co. v. Dardar
145 So. 3d 271 (Supreme Court of Louisiana, 2014)
Succession of Ursin v. Board of Levee Commissioners
104 So. 3d 534 (Louisiana Court of Appeal, 2012)
Austin v. Abney Mills, Inc.
824 So. 2d 1137 (Supreme Court of Louisiana, 2002)
Walls v. American Optical Corp.
740 So. 2d 1262 (Supreme Court of Louisiana, 1999)
Ruiz v. Oniate
697 So. 2d 1373 (Louisiana Court of Appeal, 1997)
Allen v. Carollo
674 So. 2d 283 (Louisiana Court of Appeal, 1996)
Martino v. Sunrall
619 So. 2d 87 (Louisiana Court of Appeal, 1993)
Cole v. Celotex Corp.
599 So. 2d 1058 (Supreme Court of Louisiana, 1992)
Sharkey v. Sterling Drug, Inc.
600 So. 2d 701 (Louisiana Court of Appeal, 1992)
Hampton v. Greenfield
576 So. 2d 630 (Louisiana Court of Appeal, 1991)
Babin v. Burnside Terminal
577 So. 2d 90 (Louisiana Court of Appeal, 1990)
Broussard v. Sears Roebuck and Co.
568 So. 2d 225 (Louisiana Court of Appeal, 1990)
Abate v. Healthcare Intern., Inc.
560 So. 2d 812 (Supreme Court of Louisiana, 1990)
Marcel v. Louisiana State Department of Public Health
494 So. 2d 334 (Supreme Court of Louisiana, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
492 So. 2d 103, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marcel-v-la-state-dept-of-public-health-lactapp-1986.